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Introduction 
• Antibiotic resistance in various bacteria 
• Some resistance can be attributed to 
overexpression of efflux pumps 
• Trimeric efflux complex uses proton motive force 
to move substrates through the periplasm, towards 
the extracellular space 
• TolC protomer contains single 100 Å pore 
spanning entire subunit 
• Evidence of a variety assembly mechanisms 
contributing to the formation of AcrAB-TolC 
pump 
Research objective: To obstruct a bacterial efflux pump though physical binding of  small molecule inhibitory 
compounds in order to combat substrate expulsion. 
Materials and Methods 
Virtual Screening: 
• Target site: TolC subunit (protoplasmic pore) of 
AcrAB-TolC efflux complex 
• Three source catalogs selected for screening 
(54,780 total compounds) 
• PyRx AutoDock Vina used to screen for low 
predicted binding energies 
• Electrostatic and noncovalent interactions 
• Steric parameters 
 
Results 
• No significant difference in efflux levels in 
systems without prolonged compound 
incubation 
• Efflux pump activity decreased in three out of 
five total systems with prolonged compound 
incubation 
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Discussion 
• Lead-compounds introduced immediately before efflux 
may: 
• Not be able to make it to the intended site 
• Be easily metabolized 
• Be simply effluxed 
• Efflux pump inhibition under prolonged compound 
incubation for select small molecules may: 
• Cause misfolding and conformational changes 
of the TolC protomer 
• Prevent assembly with the rest of the efflux 
complex 
 
 
 
Future Research 
• Immunostaining to determine AcrAB-TolC protein 
concentrations in vivo with and without prolonged 
compound incubation 
• Gel electrophoresis to test for protein:protein 
interactions among AcrA, AcrB, and TolC in the 
presence and absence of the lead-compounds 
• Screening of ZINC27215486 analogs to test compounds 
with similar effective binding patterns 
In Vivo Efflux Assay using Ethidium Bromide (EtBr) as 
a Fluorescent Tag   
PyRx AutoDock Vina 
